MG

Markandeya Gorantla

Active Director Managing Director DIN 03384248
DIN 03384248 First appointment Aug 2006 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 9 active board seats
Past companies 7 historical roles
Total affiliations 16 Since Aug 2006
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 01 Aug 2006
Active appointments 13
Total timeline records 16

Markandeya Gorantla (DIN 03384248) has 16 recorded board appointments in Indian companies, the first from August 2006, of which 13 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2006
Atreva Cropscience Private Limited Director · 2025 – present
Current
Revelations Biotech Private Limited Director · 2025 – present
Current
Utopia Therapeutics Private Limited Director · 2025 – present
Current
Wt Faba Biocatalyst Llp Designated Partner · 2025 – present
Current
Current
Current
Dr Gorantla Llp Designated Partner · 2019 – present
Current
Green Habitat Holdings Llp Designated Partner · 2017 – present
Current
Epr Pharmaceuticals Private Limited Additional Director · 2015 – present
Current
Epr Gene Technologies Private Limited Director · 2015 – present
Current
Grignard Chemicals Llp Designated Partner · 2015 – present
Current
Atgc Biotech Private Limited Managing Director · 2014 – present
Current
Current
Eisner Crop Sciences Private Limited Additional Director · 2016 – 2017
Previous
Isca Systems India Private Limited Director · 2016 – 2022
Previous
Virupaksha Organics Limited Additional Director · 2015 – 2016
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available